Obsessive-compulsive disorder and Tourette’s syndrome

被引:5
|
作者
Randall D. Buzan
Jay H. Shore
Christopher O’Brien
Christopher Schneck
机构
[1] University of Colorado,Department of Psychiatry
关键词
Attention Deficit Hyperactivity Disorder; Risperidone; Tardive Dyskinesia; Tourette Syndrome; Main Drug Interaction;
D O I
10.1007/s11940-000-0014-1
中图分类号
学科分类号
摘要
Obsessive-compulsive behavior (OCB) or full-blown obsessive-compulsive disorder (OCD) afflict more than 50% of patients with Tourette’s syndrome (TS) and often are more debilitating than the tic disorder itself. Medications for OCD, including selective serotonin reuptake inhibitors (SSRIs), help patients with TS and OCD, particularly in combination with low-dose antipsychotic drugs, but seldom eliminate OCD entirely. Behavioral therapies are more effective as medications for the treatment of OCD. A combination of cognitive behavioral therapy and medication is the treatment of choice for most patients with TS and OCD.
引用
收藏
页码:125 / 139
页数:14
相关论文
共 50 条
  • [1] Obsessive-compulsive disorder in Tourette syndrome
    Goodman, Wayne K.
    Storch, Eric A.
    Geffken, Gary R.
    Murphy, Tanya K.
    JOURNAL OF CHILD NEUROLOGY, 2006, 21 (08) : 704 - 714
  • [2] Tourette syndrome and obsessive-compulsive disorder
    Lombroso, Paul J.
    Scahill, Lawrence
    BRAIN & DEVELOPMENT, 2008, 30 (04): : 231 - 237
  • [3] Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease
    Muller, N
    Putz, A
    Kathmann, N
    Lehle, R
    Gunther, W
    Straube, A
    PSYCHIATRY RESEARCH, 1997, 70 (02) : 105 - 114
  • [4] Executive function in Tourette's syndrome and obsessive-compulsive disorder
    Watkins, LH
    Sahakian, BJ
    Robertson, MM
    Veale, DM
    Rogers, RD
    Pickard, KM
    Aitken, MRF
    Robbins, TW
    PSYCHOLOGICAL MEDICINE, 2005, 35 (04) : 571 - 582
  • [5] Dopaminergic activity in Tourette's syndrome and obsessive-compulsive disorder
    De Vries, Ee.
    Denys, D.
    Cath, D. C.
    Figee, M.
    Veltman, D. J.
    van der Doef, T. F.
    Boellaard, R.
    Balkom, A. J. L. M.
    Lammertsma, A. A.
    van Berckel, B. N. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S300 - S301
  • [6] Dopaminergic activity in Tourette's syndrome and obsessive-compulsive disorder
    de Vries, F. E.
    Denys, D.
    Cath, D. C.
    Figee, M.
    Vulink, N. C. C.
    Veltman, D. J.
    van der Doef, T. F.
    Boellaard, R.
    Westenberg, H. G. M.
    van Balkom, A. J. L. M.
    Lammertsma, A. A.
    van Berckel, B. N. M.
    NEUROIMAGE, 2010, 52 : S58 - S58
  • [7] Dermatological manifestations of Tourette syndrome and obsessive-compulsive disorder
    Jankovic, J
    Sekula, S
    ARCHIVES OF DERMATOLOGY, 1998, 134 (01) : 113 - 114
  • [8] Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder
    Denys, Damiaan
    de Vries, Froukje
    Cath, Danielle
    Figee, Martijn
    Vulink, Nienke
    Veltman, Dick J.
    van der Doef, Thalia F.
    Boellaard, Ronald
    Westenberg, Herman
    van Balkom, Anton
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (11) : 1423 - 1431
  • [9] The semantic Simon effect in Tourette's syndrome and obsessive-compulsive disorder
    Rankins, D.
    Bradshaw, J. L.
    Georgiou-Karistianis, N.
    BRAIN AND COGNITION, 2006, 61 (03) : 225 - 234
  • [10] Differences in dopamine release in Tourette's syndrome and obsessive-compulsive disorder
    Wong, Dean
    Raymont, Vanessa
    Brasic, James
    Kumar, Anil
    Nestadt, Gerald
    Schretlen, David
    Kuwabara, Hiroto
    Zhou, Yun
    Nandi, Ayon
    Singer, Harvey
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52